Isolated Nocturnal Hypertension: What Do We Know and What Can We Do? by Tadic M, Cuspidi C, Grassi G, Mancia G

Get full text

Strategies to meet the need for long-term data by Chalmers, J, Woodward, M, Borghi, C, Manolis, A, Mancia, G

Coronary artery disease in Africa and the Middle East by Kurdi MI, Ibrahim M, Chettaoui R, Arnaout MS, Almahmeed W, Taher MA, Mancia G

Get full text

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial by Ohkuma, T, Zoungas, S, Jun, M, Lisheng, L, Mancia, G, Marre, M, Rodgers, A, Williams, B, Woodward, M, Chalmers, J

Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial by Mehlum, MH, Liestøl, K, Julius, S, Kjeldsen, SE, Hua, TA, Rothwell, PM, Mancia, G, Parati, G, Weber, MA, Berge, E

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks by Mehlum, MH, Liestøl, K, Kjeldsen, SE, Julius, S, Hua, TA, Rothwell, PM, Mancia, G, Parati, G, Weber, MA, Berge, E

Importance of mean blood pressure and blood pressure variability for the effect of valsartan versus amlodipine on cardiovascular events and death by Mehlum, MH, Liestol, K, Kjeldsen, SE, Julius, S, Hua, TA, Rothwell, PM, Weber, MA, Berge, E, Mancia, G, Parati, G

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes by Mohammedi, K, Woodward, M, Marre, M, Colagiuri, S, Cooper, M, Harrap, S, Mancia, G, Poulter, N, Williams, B, Zoungas, S, Chalmers, J

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials... by Hua, X, Lung, TWC, Woodward, M, Salomon, JA, Hamet, P, Harrap, SB, Mancia, G, Poulter, N, Chalmers, J, Clarke, PM

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study by Ohkuma, T, Woodward, M, Jun, M, Muntner, P, Hata, J, Colagiuri, S, Harrap, S, Mancia, G, Poulter, N, Williams, B, Rothwell, P, Chalmers, J

Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial. by Arima, H, Anderson, C, Omae, T, Woodward, M, MacMahon, S, Mancia, G, Bousser, MG, Tzourio, C, Rodgers, A, Neal, B, Chalmers, J

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes by Woodward, M, Mohammedi, K, Hirakawa, Y, Zoungas, S, Williams, B, Lisheng, L, Rodgers, A, Mancia, G, Neal, B, Harrap, S, Marre, M, Chalmers, J

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON by Jun, M, Ohkuma, T, Zoungas, S, Colagiuri, S, Mancia, G, Marre, M, Matthews, D, Poulter, N, Williams, B, Rodgers, A, Perkovic, V, Chalmers, J, Woodward, M

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. by Jun, M, Ohkuma, T, Zoungas, S, Colagiuri, S, Mancia, G, Marre, M, Matthews, D, Poulter, N, Williams, B, Rodgers, A, Perkovic, V, Chalmers, J, Woodward, M

Associations between body mass index and the risk of renal events in patients with type 2 diabetes by Mohammedi, K, Chalmers, J, Herrington, W, Li, Q, Mancia, G, Marre, M, Poulter, N, Rodgers, A, Williams, B, Perkovic, V, Coresh, J, Woodward, M

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes by Woodward, M, van der Leeuw, J, Visseren, F, van der Graaf, Y, Grobbee, D, Harrap, S, Heller, S, Mancia, G, Marre, M, Poulter, N, Zoungas, S, Chalmers, J

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluatio... by van Steen, S, Woodward, M, Chalmers, J, Li, Q, Marre, M, Cooper, M, Hamet, P, Mancia, G, Colagiuri, S, Williams, B, Grobbee, D, DeVries, J, ADVANCE Collaborative Group

Blood pressure variables and cardiovascular risk: new findings from ADVANCE. by Kengne, A, Czernichow, S, Huxley, R, Grobbee, D, Woodward, M, Neal, B, Zoungas, S, Cooper, M, Glasziou, P, Hamet, P, Harrap, S, Mancia, G, Poulter, N, Williams, B, Chalmers, J

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial by Rahman, F, McEvoy, J, Ohkuma, T, Marre, M, Hamet, P, Harrap, S, Mancia, G, Rodgers, A, Rahman, F, Selvin, E, Williams, B, Muntner, P, Chalmers, J, Woodward, M

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. by Hata, J, Arima, H, Rothwell, P, Woodward, M, Zoungas, S, Anderson, C, Patel, A, Neal, B, Glasziou, P, Hamet, P, Mancia, G, Poulter, N, Williams, B, Macmahon, S, Chalmers, J